CorMedix Inc.CRMDNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank93
3Y CAGR+21.9%
5Y CAGR+7.6%
Year-over-Year Change
Research and development spending
3Y CAGR
+21.9%/yr
vs -13.2%/yr prior
5Y CAGR
+7.6%/yr
Recent acceleration
Acceleration
+35.1pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $19.33M | +390.4% |
| 2024 | $3.94M | -70.0% |
| 2023 | $13.16M | +23.2% |
| 2022 | $10.68M | -18.7% |
| 2021 | $13.13M | -1.8% |
| 2020 | $13.38M | +21.0% |
| 2019 | $11.05M | -41.3% |
| 2018 | $18.82M | -23.1% |
| 2017 | $24.49M | +55.6% |
| 2016 | $15.74M | - |